Estimating the burden of antimicrobial resistance: a systematic literature review NR Naylor, R Atun, N Zhu, K Kulasabanathan, S Silva, A Chatterjee, ... Antimicrobial Resistance & Infection Control 7, 1-17, 2018 | 552 | 2018 |
Botulinum Toxin Type‐A (BOTOX®) in the Treatment of Occipital Neuralgia: A Pilot Study M Taylor, S Silva, C Cottrell Headache: The Journal of Head and Face Pain 48 (10), 1476-1481, 2008 | 94 | 2008 |
Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis S Silva, N Arinaminpathy, R Atun, E Goosby, M Reid The Lancet Global Health 9 (10), e1372-e1379, 2021 | 91 | 2021 |
Innovative financing instruments for global health 2002–15: a systematic analysis R Atun, S Silva, FM Knaul The Lancet Global Health 5 (7), e720-e726, 2017 | 60 | 2017 |
Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study R Atun, AY Chang, O Ogbuoji, S Silva, S Resch, J Hontelez, ... BMJ open 6 (3), e009656, 2016 | 57 | 2016 |
Innovative financing for HIV response in sub–Saharan Africa R Atun, S Silva, M Ncube, A Vassall Journal of global health 6 (1), 2016 | 39 | 2016 |
Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018; 7: 58 NR Naylor, R Atun, N Zhu, K Kulasabanathan, S Silva, A Chatterjee | 35 | |
Assessing the impact of one million COVID-19 deaths in America: economic and life expectancy losses S Silva, E Goosby, MJA Reid Scientific reports 13 (1), 3065, 2023 | 31 | 2023 |
International funding for global common goods for health: an analysis using the creditor reporting system and G-FINDER databases M Schäferhoff, P Chodavadia, S Martinez, KK McDade, S Fewer, S Silva, ... Health Systems & Reform 5 (4), 350-365, 2019 | 29 | 2019 |
Building a tuberculosis-free world while responding to the COVID-19 pandemic MJA Reid, S Silva, N Arinaminpathy, E Goosby The Lancet 396 (10259), 1312-1313, 2020 | 28 | 2020 |
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis M Reid, YJP Agbassi, N Arinaminpathy, A Bercasio, A Bhargava, ... The Lancet 402 (10411), 1473-1498, 2023 | 27 | 2023 |
Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low-and middle-income countries: A modeling study S Silva, HH Ayoub, C Johnston, R Atun, LJ Abu-Raddad PLoS medicine 19 (12), e1003938, 2022 | 20 | 2022 |
Methods for estimating the burden of antimicrobial resistance: a systematic literature review protocol NR Naylor, S Silva, K Kulasabanathan, R Atun, N Zhu, GM Knight, ... Systematic reviews 5, 1-5, 2016 | 17 | 2016 |
Antimicrob. Resist NR Naylor, R Atun, N Zhu, K Kulasabanathan, S Silva, A Chatterjee, ... Infect. Control 7, 58, 2018 | 9 | 2018 |
& Robotham, JV (2018). Estimating the burden of antimicrobial resistance: a systematic literature review NR Naylor, R Atun, N Zhu, K Kulasabanathan, S Silva, A Chatterjee Antimicrobial Resistance & Infection Control 7 (1), 1-17, 0 | 9 | |
The incalculable costs of tuberculosis H Cox, J Furin The Lancet Global Health 9 (10), e1337-e1338, 2021 | 8 | 2021 |
Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study. BMJ Open. 2016; 6: e009656 R Atun, AY Chang, O Ogbuoji, S Silva, S Resch, J Hontelez Epub 2016/03/08. doi: 10.1136/bmjopen-2015-009656 PMID: 26948960, 0 | 6 | |
The health and economic benefits possible with novel tuberculosis vaccines–a modeling study in India and Indonesia S Silva, S Awad, L Abu-Raddad, R Atun, E Goosby, M Reid | 5 | 2021 |
Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018; 7 (1): 58 NR Naylor, R Atun, N Zhu, K Kulasabanathan, S Silva, A Chatterjee, ... | 5 | |
Morphological evaluation of mice zygotes experimentally infected by Brucella abortus M D’ANGELO, S SILVA, MLP SENEDEZI, RF GONÇALVES, ... Biology of Reproduction 68, 163, 2003 | 3 | 2003 |